To develop an effective immunization protocol against human serum albumin-Cys-GlyGnRH (HSA-GnRH) conjugate to delay the onset of puberty in heifers, 58 heifers ( 8 mo of age; mean ± SE BW = 203 ± 1 kg) were randomly assigned to each of six treatments: 1 ) controls, .1 mg of HSA, with diethylaminoethyl (DEAE)-dextran as adjuvant, on d 0 and 28; 2 ) .1 mg of HSA-GnRH, with DEAEdextran, on d 0; 3 ) as 2 ) and booster on d 28; 4 ) as 3 ) but boosters also on d 84, 140, 196, and 252; 5 ) as 2 ) but half the conjugate given with DEAE-dextran adjuvant and half with non-ulcerative Freund's adjuvant (NUFA), injected in two separate sites; and 6 ) as 2 ) but the conjugate given with DEAE-dextran and NUFA, emulsified and injected in two sites. The duration of the experiment was 342 d. Mean plasma GnRH antibody titers (samples every 2 wk) for heifers in Treatments 2 to 6 were 9.4 ± 1.16, 20.6 ± 2.21, 43.9 ± 2.86, 27.9 ± 2.67, and 44.5 ± 3.75% binding at a plasma dilution of 1:640. The mean number of times estrus was observed in heifers was less ( P < .05; pooled SEM = .53) in Treatments 4 ( . 2 ) and 6 (2.4) than in Treatments 1, 2, 3, and 5 (7.8, 7.0, 7.0, and 6.6, respectively). The mean interval to the onset of puberty (the first increase in plasma progesterone ≥ .5 ng/mL for ≥ 10 d with samples at 3-to 4-d intervals) was greater ( P < .05; pooled SEM = 11.6) for heifers in treatments 4 (339 d ) and 6 (276 d ) than for heifers in Treatments 1, 2, 3, and 5 (164, 159, 165, and 170 d, respectively). Mean ADG of heifers was reduced ( P < .05) in treatments 2, 3, 4, and 6 (.71, .72, .68, and .69 kg, respectively) compared with controls (.77). In summary, the multiple booster immunization treatment induced and maintained sufficient anti-GnRH titers to delay puberty for 175 d; a single immunization against GnRH with DEAE and NUFA increased antibody titers enough to delay puberty for 112 d. However, GnRH immunization treatments reduced ADG of heifers in Treatments 2, 3, 4, and 6.
Introduction
Recurrent estrus in beef heifers causes undesirable management problems (Roche and Crowley, 1973) . One method of eliminating estrus in heifers is to prevent the onset of puberty. A major endocrine event leading to first ovulation and puberty in sheep (Huffman et al., 1987) and cattle (Schams et al. 1981; Jagger et al., 1989; Evans et al., 1994) is an increase in LH pulse frequency, which is dependent on increased GnRH secretion from the hypothalamus (Schams et al., 1981) . If the action of GnRH is disrupted, the increase in gonadotropin secretion and the initiation of ovarian function will not occur. Puberty in heifers was delayed by immunization against GnRH-ovalbumin conjugate using diethylaminoethyl ( DEAE)-dextran/mineral oil as adjuvant (D'Occhio et al., 1992) and GnRH-human serum albumin ( GnRH-HSA) conjugate in Freund's complete adjuvant (Wettemann and Castree, 1994) . However, in both studies, only one protocol was used, multiple injections were required, and either responses were variable (D'Occhio et al., 1992) or small numbers of heifers were used (Wettemann and Castree, 1994) . Thus, different immunization protocols (such as single immunization with novel adjuvant combinations) should be compared to develop an effective protocol for delaying puberty and suppressing estrus.
The overall objective was to develop an immunization protocol that would induce sufficient GnRH antibody titers in heifers to prevent the attainment of puberty. Thus, the specific objectives were 1 ) to examine the effects of number of booster immunizations and 2 ) to compare the effectiveness of single immunization protocols (by mixing adjuvants having different expected antigen release patterns) with multiple immunization protocols on the persistence of GnRH antibody titers, onset of puberty, and performance of prepubertal beef heifers.
Materials and Methods

Animals and Treatments
Fifty-eight Friesian × Hereford 8-mo-old prepubertal heifers (mean ± SE BW = 203 ± 1 kg) were used. They were housed in two straw-bedded pens (with approximately equal numbers from each treatment in each pen) from the start of the experiment until d 158 and were then kept on pasture until the end of the experiment ( d 342). While housed, they were given ad libitum access to grass silage and 2 kg of rolled barley each per day. They also received 1 kg of rolled barley each per day for the final 56 d at pasture.
Heifers were randomly assigned to each of six treatments: 1 ) .1 mg of HSA in DEAE-dextran adjuvant on d 0 and 28 ( Control) ; 2 ) .1 mg of HSACys-Gly-GnRH ( HSA-GnRH) in DEAE-dextran (Sigma Chemical, Poole, Dorset, U.K.) adjuvant on d 0 ( Single) ; 3 ) as 2 ) but given booster immunization on d 28 ( P+B) ; 4 ) as in 3 ) but also boosted on d 84, 140, 196 , and 252 ( Multiple) ; 5 ) .05 mg of HSAGnRH in half the normal amount of DEAE-dextran and .05 mg of HSA-GnRH in half the normal amount of non-ulcerative Freund's adjuvant ( NUFA, Guildhay Ltd., Guildford, Surrey, U.K.), given in two separate sites on d 0 ( DEAE/NUFA-Sep) ; and 6 ) .1 mg of HSA-GnRH conjugate in an emulsion of DEAEdextran solution and NUFA oil ( DEAE/NUFA-Emul on d 0) . Corynebacterium parvum ( C. parvum; Coparvax, Calmic Medical Division, The Wellcome Foundation Ltd., London, U.K.) was incorporated with NUFA in the single immunizations to enhance the immune response. All immunizations were given as s.c. injections at two sites on the side of the neck. The HSA-GnRH conjugate was prepared as described by Finnerty et al. (1994) . Typically 6 to 8 mol of CysGly-GnRH was conjugated to 1 mol of HSA. The dose of conjugate used in this experiment was based on the successful suppression of estrus in a previous study using cyclic heifers (Prendiville et al., 1995) .
Immunogen Preparation DEAE-Dextran. The DEAE-dextran adjuvant solution was prepared as described by Crowe et al. (1994) . Briefly, DEAE-dextran (.1 g/mL for treatments 1 to 5 ) was dissolved over low heat (approximately 40°C ) in sterile distilled water, and the pH was adjusted to between 7.5 and 7.7 using saturated Tris (Sigma). The HSA-GnRH conjugate was dissolved in a sterile saline solution (.9%, pH 7.2), and equal volumes of the conjugate and DEAE-dextran solutions were mixed by stirring at 4°C for at least 2 h before injection. For Treatments 1 to 4, 5 mL per heifer was injected into two sites at each immunization. For Treatment 5, 2.5 mL of conjugate-DEAEdextran solution was injected into the first injection site.
Non-Ulcerative Freund's Adjuvant. The HSA-GnRH conjugate was dissolved in sterile saline solution (.9%, pH 7.2), and .175 mg C. parvum per immunization was added. This aqueous phase was emulsified with NUFA oil in a 1:1 proportion by forcing the liquids several times through a small orifice (double-ended 18-gauge steel needle between two syringes). The quality of emulsion formed was tested by its ability to form a droplet on water. The immunogen was prepared directly before immunization and injected at a final volume of 1.5 mL per heifer in the second injection site for heifers in Treatment 5.
Mixed Adjuvants. The emulsion used in Treatment 6 consisted of 50% aqueous phase ( 2 mL/heifer) and 50% NUFA oil ( 2 mL/heifer). The HSA-GnRH conjugate (.1 mg/heifer) and C. parvum (.175 mg/heifer) were dissolved in 1 mL of .9% sterile saline solution (pH 7.2). The DEAE-dextran (.125 g/heifer) was dissolved in 1 mL of sterile water (pH adjusted between 7.5 and 7.7 using saturated Tris). The aqueous phase (DEAE and conjugate solutions) and NUFA oil were emulsified (in a glass beaker on ice) with the aid of a direct probe sonicator for 60 to 90 s. The quality of the emulsion was tested by its ability to form a droplet on water. The final injection volume was 4 mL per heifer injected in two sites in the neck.
Experimental Procedures
Jugular blood samples were collected twice weekly ( 3 to 4 d apart), using lithium heparin-coated tubes, for determination of plasma progesterone and estradiol concentrations and GnRH antibody titers. Plasma was obtained after centrifugation at 1,600 × g for 20 min. Samples were then frozen at −20°C until they were assayed. Plasma GnRH antibody titers were measured in samples collected approximately every 2 wk with a RIA precipitation technique using [ 125 I]-GnRH (Amersham, U.K.) as described by Finnerty et al. (1994) . The GnRH antibody titers are presented as percentage binding at a plasma dilution of 1:640 in assay buffer. The intraassay CV ( n = 10) for standard bovine plasma with 48.7% binding at a dilution of 1: 640 was 3.3%, and the interassay CV ( n = 20) was 6.4%. Progesterone concentrations were determined in samples collected twice weekly using the non-extraction RIA described by Ronayne and Hynes (1990) . The intraassay CV ( n = 6 ) for samples containing .2, .9, and 2.5 ng of progesterone/mL were 5.6, 5.9, and 3.2%, respectively. The interassay CV for the same samples ( n = 21) were 13.5, 8.6, and 9.6%, respectively. The sensitivity of the assay was .03 ng of progesterone/mL. Estradiol concentrations were determined in samples at 14-or 28-d intervals from d 70 for heifers in Control, P+B, and Multiple immunization groups by the method described by Prendiville et al. (1995) using the Serono Estradiol MAIA assay kit (Biodata S.p.A., Montecelio, Italy). The intraassay CV ( n = 4 ) for samples with a mean of .9, 2.6, and 5.9 pg of estradiol/mL of serum were 12.0, 6.2, and 9.5%, respectively. The interassay CV ( n = 6 ) for the same samples were 17.5, 15.6, and 18.8%, respectively. The sensitivity of the assay was .2 pg of estradiol/mL.
Onset of puberty was defined as the 1st d when plasma progesterone increased to ≥ .5 ng/mL in at least three consecutive samples, or it was assigned as the day of slaughter for heifers that did not reach puberty during the experiment. The ovaries of the six heaviest heifers, selected at the start of the experiment, from each treatment were examined ultrasonically every week (from d 62 until they reached puberty or the end of the experiment), to determine numbers of medium ( 5 to 9 mm) and large ( ≥ 10 mm) follicles, as described previously by Savio et al. (1988) and Murphy et al. (1990) . The ultrasound scanner (Dynamic Imaging, Livingston, Scotland) was fitted with a 7.5-MHz linear array rectal transducer. Estrus was checked twice daily with the aid of a vasectomized bull fitted with a marking harness. Heifers were weighed every 2 wk and slaughtered on d 342. After slaughter, cold carcass weights, conformation scores (scale of 1 to 5; 1 = best conformation), and fat scores (scale of 1 to 5; 1 = leanest) were determined. Dressing percentage was calculated based on cold carcass weight and BW on d 342.
Statistical Analyses
Two heifers died early in the experimental period (one in Treatment 3 due to pneumonia and one in Treatment 6 due to hemorrhage of a pulmonary blood vessel), and one heifer in Treatment 4 was retrospectively identified as being pubertal at the start of the experiment; the data from these heifers were not included in the statistical analyses. Follicular data for heifers assigned to Treatment 4 were excluded from statistical analyses because only one heifer from the subgroup scanned reached puberty. Data relating to antibody titers (excluding the controls), days to puberty, body growth, carcass characteristics, estradiol concentrations (Control, P+B, and Multiple treatments), and follicle data were analysed using ANOVA procedures for a completely randomized design (Gill, 1978) . Differences between treatments were determined using Fisher's one-tailed t-test for follicle size and number, and, for all other data, the two-tailed least significant difference test. Chi-square analyses were used to test differences between the proportion of heifers in each treatment that reached puberty. Simple correlation coefficients between different traits were determined for heifers in the GnRH immunization treatments.
Results
Antibody Titers
The GnRH antibody titer profiles are presented in Figure 1 . The percentage of binding in the control heifers ranged from 0 to 1.9%, which represents nonspecific binding. Mean antibody titers were greater ( P < .05) in heifers in the Multiple and DEAE/NUFAEmul treatments than in those in all other immunization treatments. In the Multiple treatment, titers increased after the first booster to a mean ± SE of 41 ± 2.4% binding on d 35, then decreased to 29 ± 2.8% until d 84. After the second booster, titers increased again and remained between 46 ± 2.3 and 60 ± 2.6% binding until the end of the experiment. The titers for heifers in the DEAE/NUFA-Emul treatment increased gradually to 26 ± 3.2% binding by d 35, 41 ± 5.2% by d 84, and 60 ± 4.3% by d 140; throughout the rest of the experiment they remained between 45 ± 4.5 and 60 ± 3.1%. Titers for heifers in the Single treatment increased to 15 ± 2.6% binding on d 35, decreased to 8 ± 1.8% on d 56, and remained at approximately 8% for the remainder of the experiment. Titers for heifers in the P+B treatment increased to a maximum of 42 ± 4.2% binding on d 35, decreased slowly to 16 ± 4.4% by d 196, and remained at approximately 16% until the end of the experiment. Titers for heifers in the DEAE/ NUFA-Sep treatment increased gradually to 42 ± 2.8% binding by d 140, decreased to 30 ± 5.4% binding by d 196, and remained between 23 ± 5.7 and 30 ± 5.4% for the remainder of the experiment. The duration of titers > 20% binding was greater ( P < .05) for heifers allocated to Multiple, DEAE/NUFA-Sep, and DEAE/ NUFA-Emul treatments than P+B or Single treatments; heifers in the P+B treatment had a greater duration ( P < .05) of increased titers than those in the Single treatment (Table 1) .
Reproductive Activity
Mean onset of puberty in control heifers was on d 164 ± 8 of the experiment (approximately 13 mo of age; Table 2); it was delayed ( P < .05) in heifers assigned to either the Multiple ( d 339 ± 1.8) or DEAE/NUFA-Emul ( d 276 ± 27) treatments compared with controls and other GnRH-immunized heifers ( Table 2 ). The mean number of estrous periods detected per heifer was decreased ( P < .05) for heifers in the Multiple and DEAE/NUFA-Emul treatments compared with heifers in other treatments ( Table 2 ). The proportion of heifers that were cyclic at the end of the experiment ( d 342) was lower ( P < .05) in the Multiple and DEAE/NUFA-Emul treatments than in all other treatments (Table 3 ). In addition, the number of estrous periods during the experiment was lower ( P < .05) in heifers assigned to the Multiple treatment than in those on the DEAE/NUFA-Emul treatment. There was no difference in the mean number of medium follicles before or after puberty between control or GnRH-immunized heifers (data not presented). Between 49 and 63 d before the onset of puberty, the number of large follicles was lower ( P < .05) in heifers in the Single, P+B, DEAE/NUFA-Sep, and DEAE/NUFA-Emul treatments (.2 ± .14, .1 ± .07, .2 ± .21, and .2 ± .14, respectively) than in control heifers (.6 ± .31). During the other periods before puberty (i.e., 0 to 42 d before puberty), there was no difference in the number of large follicles in GnRHimmunized and control heifers. Mean estradiol concentrations ( d 70 to 342) were lower ( P < .05) for heifers in the Multiple (.7 ± .10 pg/ mL) treatment than for heifers in Control and P+B treatments (1.1 ± .13 and 1.5 ± .20 pg/mL, respectively). In addition, during the period before puberty ( d 70 to 164), mean estradiol concentrations were not different between Control and P+B heifers (1.2 ± .12 and 1.5 ± .22 pg/mL, respectively).
Performance
Overall ADG was reduced ( P < .05) in GnRHimmunized heifers (except for those in the DEAE/ NUFA-Sep treatment) compared with controls (.71 ± .01 and .77 ± .03 kg, respectively). However, there was no difference among treatments in final live weight, cold carcass weight, dressing percentage, conformation score, or fat score (Table 4) .
Correlation Coefficients Between Traits
Correlation coefficients between day of onset of puberty, day of peak antibody titer, peak antibody Table 4 . Mean and SEM of ADG, final live weight, and carcass characteristics for controls and heifers immunized against a HSA-GnRH conjugate with either single or multiple (primary and booster, P + B; six immunizations, Multiple) immunization protocols and slaughtered 342 days after the start of an experiment in which treatment was initiated at 8 months of age. The adjuvants used were either diethylaminoethyl-dextran (DEAE) or non-ulcerative Freund's adjuvant (NUFA)
a Each adjuvant was mixed separately with conjugate and injected separately. b The oil and aqueous adjuvants were emulsified and injected together. c Scale 1 to 5 ( 1 = best conformation). d Scale 1 to 5 ( 1 = leanest).
x,y Means within a row without common superscripts are different ( P < .05). titer, and mean antibody titer were positive ( r ≥ .38; P ≤ .01). There were negative correlations ( P < .01) between day of puberty and number of recurrent ovulations ( r = −.95) and between day of puberty and number of estrous periods ( r = −.96). There was a positive correlation ( r = .99; P < .01) between number of estrous periods and number of recurrent ovulations.
Discussion
The main findings of this experiment with prepubertal heifers were that 1 ) the Multiple immunization treatment gave high and persistent antibody titers, sufficient to delay puberty for at least 175 d, 2 ) the single immunization protocol, for which the conjugate was emulsified with two adjuvants, delayed puberty for 112 d, 3 ) ADG of heifers was reduced in all GnRH immunization treatments, except in the DEAE/NUFA-Sep treatment, although carcass weight was not affected, and 4 ) antibody titers in the Single, P+B, and DEAE/NUFA-Sep treatments were decreasing before the expected onset of puberty and were probably of insufficient magnitude to delay puberty.
The onset of puberty in control heifers in this experiment occurred 164 d after primary immunization (at approximately 13 mo of age). This is typical for the types of heifers and management conditions used in this study (Moran et al., 1990) . Antibody titers in the Single treatment were low throughout the experiment, whereas titers in the P+B and DEAE/ NUFA-Sep treatments peaked 129 and 38 d, respectively, before the expected onset of puberty (i.e., d 164). This early, but short-lived, increase in titers is the likely cause of the failure of these treatments to delay puberty. One can speculate that to be biologically active antibody titers against GnRH must be high at the expected time of puberty. Indeed, in the Multiple and DEAE/NUFA-Emul treatments, for which titers were peaking/plateauing during the peripubertal period, puberty was significantly delayed, indicating that the antibodies were indeed binding endogenous GnRH.
Although there are a number of reports on GnRH immunization in postpubertal heifers and cows (Adams and Adams, 1990; Hoskinson et al., 1990; D'Occhio et al., 1992; Prendiville et al., 1995) , there are only two reports in which GnRH immunization was initiated before puberty (D'Occhio et al., 1992; Wettemann and Castree, 1994) . Wettemann and Castree (1994) delayed puberty for 11 wk after primary GnRH immunization at 12 mo of age with a booster immunization 6 wk later. In the study of D 'Occhio et al. (1992) , 18 heifers were immunized against GnRH at 6, 10, and 16 mo of age and compared with 34 controls. The controls became pubertal over a period of 16 to 26 mo of age. At 26 mo of age, 5/18 (28%) immunized and 32/34 (94%) control heifers were pubertal; the first immunized heifer to become pubertal did so at approximately 19 mo of age. The authors hypothesized that heifers would have remained prepubertal for a longer period if they had been given additional booster immunizations. This is supported by data from the Multiple treatment in the current experiment; the two heifers that eventually became pubertal in that group did so 80 d after the last booster, and it is likely that this could have been prevented if an additional booster had been given at 56 d after the last booster.
Performance was generally reduced in GnRHimmunized heifers, regardless of whether puberty was delayed. Some studies in postpubertal heifers (e.g., Adams and Adams, 1990 ) reported a reduction in ADG due to GnRH immunization. Furthermore, Adams and Adams (1990) demonstrated that the decreased performance was compensated for by the use of estrogenic implants. Therefore, the implication is that the decreased growth is due to reduced estradiol secretion from anestrous ovaries devoid of estrogen-active dominant follicles, because estradiol is known to be anabolic (Moran et al., 1990 ) and removal of the ovaries generally leads to reduced ADG (Zinn et al., 1989) . Puberty was delayed by GnRH immunization in the Multiple and DEAE/NUFA-Emul treatments; based on reduced estradiol concentrations in the Multiple group, the reduced growth in these two groups can be explained. However, the reason for the decreased ADG in GnRH-immunized heifers in which puberty was not delayed and estradiol concentrations were not reduced ( P + B group) is not immediately clear. This raises the question of an effect of antibody titers per se on animal performance. In recent studies with PGF 2a immunization, ADG was reduced following booster immunizations (Crowe et al., 1995b) . With PGF 2a immunization, a persistent corpus luteum forms, estrus is prevented, and there is normal turnover of dominant follicles. However, performance was reduced during the 28-d period after PGF 2a booster immunization, indicating that the effect on ADG may be due to stimulation of the immune system per se; data from the current study supports this possibility. Thus, the decrease in ADG of GnRHimmunized heifers cannot be explained by the absence of estrogen-active dominant or medium-sized follicles and may be related in some way to stimulation of the immune system. There were differences in the immune and biological responses following single immunization with DEAE and NUFA adjuvants injected simultaneously, but separately, vs emulsified together. The DEAE adjuvant is water-soluble and tends to give a high but relatively short-lived immune response to the antigen (Crowe et al., 1994; Finnerty et al., 1994) . In contrast, the oil-based adjuvant NUFA gives a slower but more persistent response (Finnerty et al., 1994; Crowe et al., 1995a) , presumably due to the better depot effect of the oil-derived emulsion. The antibody titers following the emulsified treatment may have been higher because the combined emulsified product gives an overall slower release of the total dose of conjugate from the depot sites in the animal compared with their separate use. However, a similar emulsification treatment with PGF 2a immunization (Crowe et al., 1995a) was only marginally effective. The difference is likely due to the improved method of emulsification (sonication) and the increased proportion of oil used in the DEAE/NUFA emulsion for the current experiment with GnRH immunization.
In summary, a multiple booster immunization protocol for GnRH immunization of prepubertal heifers delayed puberty for at least 5 mo. A single immunization protocol using two adjuvants emulsified with the conjugate delayed puberty for approximately 4 mo. Clearly, the time of initiation of immunization using an effective protocol is critical for achieving adequate antibody titers during the peripubertal period and for the successful prevention of puberty in beef heifers. Performance was reduced following GnRH immunization, but carcass weight was not adversely affected in this study.
Implications
These results demonstrate that the onset of puberty can be delayed for a prolonged period in heifers by gonadotropin-releasing hormone immunization at the appropriate time before puberty, thus eliminating the expression of estrus and decreasing the risk of unwanted pregnancies during the production period of beef heifers. Furthermore, a single immunization protocol (using a combination of water-soluble and oilbased adjuvants emulsified together) is effective at delaying puberty for, on average, 112 d. However, gonadotropin-releasing hormone immunization decreases average daily gain, which limits its use for suppressing estrus in beef heifers slaughtered at 16 to 20 mo of age.
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